ALUR · Allurion Technologies, Inc.
$0.39
-0.29 (-42.62%)
At close · Mar 9
Going-concern doubt
— flagged May 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Because the amount and timing of such financings are uncertain, the Company has concluded that management’s plans do not alleviate substantial doubt about its ability to continue as a going concern for a reasonable period of time.”View the 10-Q filed May 15, 2026
Market Cap
$2.01M
Shares
1.00M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.39
Open$0.56
Day$0.32–0.60
52W close$0.39–3.58
Avg vol 30d5.4M
Short int2K · 0.2% float · 1.0d
Short vol27%
Last earningsNov 12, 2025
DataMar 2021–Mar 2026
Filing10-Q · May 15
Up next
filed May 15, 2026
Equibles Rating
blended score · not investment adviceOverall
Strong Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Bullish
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 14.5 · calm
Equity put/call 0.58
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−81%
below
Price vs 50-day avg
−70%
below
RSI (14)
30
neutral
MACD trend
Negative
52-week position
0%
near low
Volume (OBV)
Bullish div.
accumulating
Momentum
relative strength
1-month return
−65%
trailing
6-month return
−82%
trailing
YTD return
−69%
this year
Relative strength
−85%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $1 › 200d $2 — 200d above 50d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.20% of float · ▼ -54.7% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
3 holders — near 3-yr low, contrarian setup
Fundamentals
Revenue growth
−53%
Y/Y
Gross margin
63%
contracting
EPS growth
−19%
Y/Y
Free cash flow
$-29.6M
Quant / Vol
risk profile
Volatility
138%
annualized · 1-yr
Max drawdown
−89%
past year
ATR
58.4%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Prior guidance
period ended
· from the 8-K filed Aug 13, 2024
Full-year 2024 revenue
· full-year 2024
$40M – $45M
Growth in procedure volume
· full-year 2024
10% – 15%
Guided vs delivered
· last 1 settled
Full-year 2024 revenue
full-year 2024
guided $40M – $45M
$32.11M
Miss −24.4%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−81%
Bearish
Price vs 50-day avg
−70%
Bearish
RSI (14)
30
Neutral
MACD trend
Negative
Bearish
52-week position
0%
Bearish
Volume (OBV)
Bullish div.
Bullish
Market signals — smart money & positioning
Bullish · 1 of 6
Trend (MA cross)
No cross
50d $1 › 200d $2 — 200d above 50d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.20% of float · ▼ -54.7% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
3 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
Range low $0
Now $0 · 0%
Range high $4
vs 200-day avg -81%
vs 50-day avg -70%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ALUR
this stock
Allurion Technologies, Inc.
|
$2.01M | -68.7% | -52.6% | — | 0.2% |
|
ABT
Abbott Laboratories
|
$188.69B | -13.5% | +5.7% | 30.3 | 1.2% |
|
MDT
Medtronic plc
|
$120.46B | -2.0% | +8.4% | 23.2 | 1.1% |
|
SYK
Stryker Corp
|
$116.27B | -13.8% | +11.2% | 31.4 | 1.8% |
|
BSX
Boston Scientific Corp
|
$69.27B | -49.9% | +12.5% | 19.4 | 1.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Reducing
Holders
3
- % held
- 0.0%
- Net QoQ
- -6.1M sh
- Top holder
- LONGFELLOW INVESTMENT MAN…
Held
Float
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ALUR | -45.1% | -65.0% | -82.4% | -67.1% | -68.7% |
| SPY | -1.2% | -1.8% | +2.6% | -1.1% | -0.5% |
| vs SPY | -43.9% | -63.2% | -85.1% | -66.0% | -68.2% |